pharmaphorum

OCTOBER 3, 2022

Amylyx Pharmaceuticals’ Relyvrio – a new treatment for amyotrophic lateral sclerosis (ALS) approved by the FDA on Thursday, after review of the data from its phase 2 trial – was the next day set at a list price of $158,000 per year in the US, sparking outcry. ALS affects over 30,000 people in the US.

Insurance 52

Insurance FDA 52

PharmaShots

FEBRUARY 17, 2023

Iveric Bio Reports the US FDA Acceptance of NDA and Granted Priority Review of Avacincaptad Pegol for Geographic Atrophy Date: Feb 17, 2023 | Tags: Iveric Bio, Avacincaptad Pegol, Geographic Atrophy, Regulatory, US, FDA, NDA, Priority Review ALX Oncology Reports the First Patient Dosing of Evorpacept in the P-I Study (ASPEN-07) for the Treatment of (..)

FDA 40

FDA Vaccines 40

pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Communication 52

Communication 52

European Pharmaceutical Review

MAY 22, 2023

Smart contracts, which are essential for easing international trade and logistics operations, can enable the user to track fake returns to the producer and supplier using RFID tags. In conclusion, Kordestani et al. Blockchain offers the possibility of non-modifiable data uploading with traceability and low-cost data storage.

92

92

European Pharmaceutical Review

AUGUST 24, 2022

tag ® , inspired by the unique features of microtubule biology and perfectly suited for DAR 2 and DAR 4 ADCs. Fu Z, Li S, Han S, et al. Zacharias N, Podust V, Kajihara K, et al. Modi S, Saura C, Yamashita T, et al. Kasper M, Lassak L, Vogl A, et al. Schumacher D, Helma J, Mann F, et al. 2021;18(6):327-344.

Compounding 84

Compounding Pharmaceutical Companies Pharmaceutical Companies 84

European Pharmaceutical Review

JUNE 8, 2023

Methods of the microbial biosurfactant study The first stage of the downstream method combined TAG selective removal from glycolipids. Overall, Nascimento et al. This indicates that scalable fermentations and downstream processes are sub-optimised.

68

68

pharmaphorum

OCTOBER 21, 2021

Vounatsos also insisted that Aduhelm’s price tag has not been a factor discouraging treatment with the drug. Biogen stumped up $1.525 billion upfront for rights to the drug and another Sage candidate for neurological diseases last year, when the expectation was that Aduhelm was unlikely to get FDA approval.

Insurance 119

Insurance FDA 119